Copyright
©The Author(s) 2023.
World J Gastroenterol. Dec 21, 2023; 29(47): 6111-6121
Published online Dec 21, 2023. doi: 10.3748/wjg.v29.i47.6111
Published online Dec 21, 2023. doi: 10.3748/wjg.v29.i47.6111
Table 1 Baseline patient characteristics
Characteristic | All, n = 75 |
Age in yr, median [IQR] | 49 [36, 62] |
Male/Female, n (%) | 45 (60.0)/30 (40.0) |
Disease duration in yr, median [IQR] | 8 [5, 13] |
Disease extent, n (%) | |
Extensive colitis | 45 (60.0) |
Left-sided colitis | 24 (32.0) |
Proctitis | 6 (8.0) |
CAI by the Rachmilewitz index, median [IQR] | 0 [0, 1] |
MES, n (%) | |
MES 0 | 43 (57.3) |
MES 1 | 32 (42.7) |
UCEIS, n (%) | |
UCEIS 0 | 39 (52.0) |
UCEIS 1 | 17 (22.7) |
UCEIS 2 | 13 (17.3) |
UCEIS 3 | 6 (8.0) |
UCCIS, median [IQR] | 0 [0, 6.7] |
FC in mg/kg, median [IQR] | 174 [43, 810] |
Medication used during the study, n (%) | |
Oral 5-ASA | 48 (64.0) |
Suppository steroids | 2 (2.7) |
Systemic steroids | 9 (12.0) |
Immunomodulators | 23 (30.7) |
Biologics | 30 (40.0) |
Table 2 Receiver-operating characteristic analysis of fecal calprotectin and Ulcerative Colitis Colonic Index of Severity for predicting Mayo Endoscopic Subscore 0
Factor | FC | UCCIS |
Cut-off value | 385 | 6.6 |
AUC (95%CI) | 0.858 (0.770-0.946) | 0.987 (0.969-1.000) |
PPV | 0.793 | 0.992 |
NPV | 0.804 | 0.994 |
Sensitivity | 0.719 | 0.992 |
Specificity | 0.804 | 0.985 |
Accuracy | 0.800 | 0.947 |
Table 3 Comparison of accuracy of relapse prediction between fecal calprotectin levels, Ulcerative Colitis Colonoscopic Index of Severity, Mayo Endoscopic Subscore, and Ulcerative Colitis Endoscopic Index of Severity
Factor | Sensitivity | Specificity | PPV | NPV | Accuracy |
FC ≥ 323 | 0.500 | 0.933 | 0.833 | 0.737 | 0.760 |
UCCIS ≥ 10.2 | 0.750 | 0.898 | 0.667 | 0.930 | 0.867 |
MES 1 | 0.833 | 0.702 | 0.469 | 0.930 | 0.733 |
UCEIS ≥ 2 | 0.722 | 0.895 | 0.684 | 0.911 | 0.853 |
- Citation: Ishida N, Ito T, Takahashi K, Asai Y, Miyazu T, Higuchi T, Tamura S, Tani S, Yamade M, Iwaizumi M, Hamaya Y, Osawa S, Sugimoto K. Comparison of fecal calprotectin levels and endoscopic scores for predicting relapse in patients with ulcerative colitis in remission. World J Gastroenterol 2023; 29(47): 6111-6121
- URL: https://www.wjgnet.com/1007-9327/full/v29/i47/6111.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i47.6111